4 completed, 1 terminated. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Terminated 1 |
Follow insulin glulisine: new trials by email Literature Review of insulin glulisine trials Research Report on insulin glulisine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease Insulin glulisine, Placebo - Mild Cognitive Impairment, Alzheimer's Disease (AD) | Phase 2 | Terminated | HealthPartners Institute | 49 | 2015-09-28 | 2020-04-09 |
| Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes NPH, Insulin LISPRO, Insulin glulisine - Diabetes During Pregnancy | Phase 2 | Completed | Sansum Diabetes Research Institute | 17 | 2013-04-01 | 2018-04-18 |
| Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients. Insulin glulisine, Saline - Alzheimer's Disease | Phase 2 | Completed | HealthPartners Institute | 12 | 2011-09-01 | 2015-10-19 |
| Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus Insulin lispro, recombinant human hyaluronidase PH20, Insulin aspart - Diabetes Mellitus, Type 1 | Phase 2 | Completed | Halozyme Therapeutics | 135 | 2010-08-01 | 2019-02-26 |
| Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus Insulin lispro, Insulin aspart, Recombinant human hyaluronidase PH20 - Diabetes Mellitus, Type II | Phase 2 | Completed | Halozyme Therapeutics | 132 | 2010-08-01 | 2014-08-20 |
Alzheimer Disease (2) · Cognition Disorders (1) · Cognitive Dysfunction (1) · Diabetes Mellitus, Type 1 (1) · Diabetes Mellitus, Type 2 (1) · Diabetes, Gestational (1)
Halozyme Therapeutics (2) · HealthPartners Institute (2) · Sansum Diabetes Research Institute (1)
United States (5)
Douglas Muchmore, M.D. (2) · Michael H Rosenbloom, MD (2) · Kristin Castorino, DO (1) · Leonie Mattison, PhD (1)